Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan Response by Copeptin Level in Heart Failure
NCT01346072Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in heart failure (HF), sponsored by University of North Carolina at Chapel Hill. Started Apr 2011; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01346072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346072.